Nautilus Biotechnology, Inc. - Common Stock (NQ:NAUT)

2.135 -0.135 (-5.95%)

Streaming Delayed Price Updated: 10:56 AM EDT, Jun 26, 2026 Add to My Watchlist

Price and Volume

Volume	404,544
Open	2.230
Bid (Size)	2.130 (900)
Ask (Size)	2.140 (1,100)
Prev. Close	2.270
Today's Range	1.870 - 2.245
52wk Range	0.6200 - 4.310
Shares Outstanding	124,094,390
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Nautilus (NAUT) Q1 2026 Earnings Transcript ↗

June 02, 2026

Nautilus (NAUT) Q1 2026 Earnings Transcript

Via The Motley Fool

Nautilus Biotechnology Reports First Quarter 2026 Financial Results

April 28, 2026

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Performance

YTD	+11.8%	+11.8%
1 Month	-12.1%	-12.1%
3 Month	-43.5%	-43.5%
6 Month	+7.8%	+7.8%
1 Year	+169.1%	+169.1%

More News

Forget Neuralink: The Real Brain Tech Trade Has 10 Names You’ve Never Heard ↗

April 25, 2026

Via InvestorPlace

Nautilus Biotechnology Inc (NASDAQ:NAUT) Reports Narrower Q4 Loss, Maintains 2027 Cash Runway ↗

February 26, 2026

Via Chartmill

Earnings Scheduled For October 28, 2025 ↗

October 28, 2025

Via Benzinga

Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026

April 09, 2026

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Q1 Virtual Investor Summit Presentations Now Available On Demand

March 26, 2026

Via ACCESS Newswire

Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference

March 24, 2026

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)

March 20, 2026

Via ACCESS Newswire

Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform

March 18, 2026

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales

March 02, 2026

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus (NAUT) Q4 2025 Earnings Call Transcript ↗

February 26, 2026

Via The Motley Fool

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results

February 26, 2026

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026

February 24, 2026

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference

February 19, 2026

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

February 05, 2026

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease

January 28, 2026

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus Biotechnology Launches Early Access Program for Novel Single-Molecule Proteomics Platform, Starting with Tau Proteoforms Assay

January 08, 2026

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Which stocks are moving on Monday? ↗

November 03, 2025

Via Chartmill

Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging

November 03, 2025

From Nautilus Biotechnology Inc.

Via GlobeNewswire

Nautilus (NAUT) Q3 2025 Earnings Call Transcript ↗

October 28, 2025

Via The Motley Fool

Nautilus Biotechnology Reports Third Quarter 2025 Financial Results

October 28, 2025

From Nautilus Biotechnology Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

October 24, 2025

Via Benzinga

What's going on in today's session ↗

October 21, 2025

Via Chartmill

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 15, 2025

Via Benzinga

Frequently Asked Questions

Is Nautilus Biotechnology, Inc. - Common Stock publicly traded?

Yes, Nautilus Biotechnology, Inc. - Common Stock is publicly traded.

What exchange does Nautilus Biotechnology, Inc. - Common Stock trade on?

Nautilus Biotechnology, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Nautilus Biotechnology, Inc. - Common Stock?

The ticker symbol for Nautilus Biotechnology, Inc. - Common Stock is NAUT on the Nasdaq Stock Market

What is the current price of Nautilus Biotechnology, Inc. - Common Stock?

The current price of Nautilus Biotechnology, Inc. - Common Stock is 2.135

When was Nautilus Biotechnology, Inc. - Common Stock last traded?

The last trade of Nautilus Biotechnology, Inc. - Common Stock was at 06/26/26 10:56 AM ET

What is the market capitalization of Nautilus Biotechnology, Inc. - Common Stock?

The market capitalization of Nautilus Biotechnology, Inc. - Common Stock is 264.94M

How many shares of Nautilus Biotechnology, Inc. - Common Stock are outstanding?

Nautilus Biotechnology, Inc. - Common Stock has 265M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.